Dacomitinib in Lung Cancer With Uncommon EGFR Mutations
Dacomitinib in Lung Cancer With Uncommon EGFR Mutations
Active, not recruiting · NCT04504071 · Registry updated 2025-09-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dacomitinib in Lung Cancer With Uncommon EGFR Mutations | EGF-R Positive Non-Small Cell Lung Cancer; Non-small Cell Lung Cancer Metastatic | Active, not recruiting | Phase 2 | 2025-09-08 | NCT04504071 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Chest Hospital | 116 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai Chest Hospital | Shanghai | China | 83 |